{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:59:44Z","timestamp":1774025984782,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ygyno.2011.03.025","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T00:13:17Z","timestamp":1303690397000},"page":"178-182","source":"Crossref","is-referenced-by-count":21,"title":["Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta"],"prefix":"10.1016","volume":"122","author":[{"given":"Margit","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kindelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Nagymanyoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wing","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Fichorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilmos","family":"Fulop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2011.03.025_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.seminoncol.2008.12.009","article-title":"Management of gestational trophoblastic neoplasia","volume":"36","author":"Horowitz","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0010","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199612053352306","article-title":"Chorionic tumors","volume":"335","author":"Berkowitz","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1525-1438.2000.00002.x","article-title":"Combining the staging system of the international Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of the Working committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society","volume":"10","author":"Kohorn","year":"2000","journal-title":"Int J Gynecol Cancer"},{"issue":"9742","key":"10.1016\/j.ygyno.2011.03.025_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0025","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0020-7292(98)80010-6","article-title":"Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT\u201425years experiences of KRI-TRD","author":"Kim","year":"1998","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0030","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients","author":"Bower","year":"1997","journal-title":"J Clin Oncol"},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2011.03.025_bb0035","first-page":"199","article-title":"Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score>or=7","volume":"55","author":"Lurain","year":"2010","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0040","unstructured":"Lewis SH, Perrin E. Pathology of the Placenta 2nd edition. 1999."},{"key":"10.1016\/j.ygyno.2011.03.025_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/excr.1996.0273","article-title":"Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A","volume":"227","author":"Crescimanno","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00049525","article-title":"Mechanism of trophoblast invasiveness and their control: the role of proteases and protease inhibitors","volume":"9","author":"Lala","year":"1994","journal-title":"Cancer Metast Rev"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s004410050987","article-title":"Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta","volume":"291","author":"Huppertz","year":"1998","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0060","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.humrep.a136024","article-title":"Gelatinase and oncofetal fibronectin expression is dependent on integrin expression on human trophoblasts","volume":"10","author":"Bishof","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00414172","article-title":"Immunohistochemical localization of serine-protease inhibitors in the human placenta","volume":"278","author":"Castellucci","year":"1994","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ygyno.2011.03.025_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/gyno.1999.5564","article-title":"Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta","volume":"75","author":"Vegh","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/153537020623100103","article-title":"Role of matrix metalloproteinase-7 (Matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis","volume":"231","author":"Masanori","year":"2006","journal-title":"Exp Biol Med"},{"issue":"8","key":"10.1016\/j.ygyno.2011.03.025_bb0090","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/13543776.2010.488221","article-title":"Metalloproteinase binding proteins: WO2009097397","volume":"20","author":"Itoh","year":"2010","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"10.1016\/j.ygyno.2011.03.025_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexmp.2007.08.014","article-title":"CD147 immunoglobulin superfamily receptor function and role in pathology","volume":"83","author":"Iacono","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2011.03.025_bb0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2613.2010.00709.x","article-title":"Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer","volume":"91","author":"Garc\u00eda","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2407-9-188","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature","volume":"9","author":"Andrea","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1083\/jcb.200807195","article-title":"Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited","volume":"185","author":"Sabeh","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2011.03.025_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.matbio.2009.04.006","article-title":"Expression and function of matrix metalloproteinase (MMP)-28","volume":"28","author":"Rodgers","year":"2009","journal-title":"Matrix Biol"},{"issue":"5","key":"10.1016\/j.ygyno.2011.03.025_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/1541-7786.MCR-10-0139","article-title":"Mechanisms of motility in metastasizing cells","volume":"8","author":"Yilmaz","year":"2010","journal-title":"Mol Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2011.03.025_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(02)01088-0","article-title":"Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer","volume":"301","author":"Ahokas","year":"2002","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.ygyno.2011.03.025_bb0130","first-page":"524","article-title":"Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer","volume":"38","author":"Xue","year":"2009","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.ygyno.2011.03.025_bb0135","first-page":"1423","article-title":"Vasculogenic mimicry of human ovarian cancer cells: role of CD147","volume":"35","author":"Millimaggi","year":"2009","journal-title":"Int J Oncol"},{"issue":"19","key":"10.1016\/j.ygyno.2011.03.025_bb0140","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/0008-5472.CAN-10-1584","article-title":"Novel matrix metalloproteinase inhibitor [18F] Marimastat-Aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer","volume":"70","author":"Keller","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.ygyno.2011.03.025_bb0145","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/MCB.01775-07","article-title":"Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding","volume":"28","author":"Butler","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.03.025_bb0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2005.12.020","article-title":"A phase III randomized trial of BAY 12\u20139566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel\/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study","volume":"102","author":"Hirte","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T05:09:49Z","timestamp":1560143389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0090825811002332"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.03.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}